Literature DB >> 33834305

Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations.

Gunay Uludag1, Neil Onghanseng1, Anh N T Tran1, Muhammad Hassan1, Muhammad Sohail Halim1,2, Yasir J Sepah1,2, Diana V Do1, Quan Dong Nguyen3.   

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with obstetrical complications, thrombotic complications involving both arteries and veins, and non-thrombotic manifestations affecting multiple other systems presenting in various clinical forms. Diagnosis requires the presence of antiphospholipid antibodies. The exact pathogenesis of APS is not fully known. However, it has recently been shown that activation of different types of cells by antiphospholipid antibodies plays an important role in thrombosis formation. Ocular involvement is one of the important clinical manifestations of APS and can vary in presentations. Therefore, as an ophthalmologist, it is crucial to be familiar with the ocular findings of APS to prevent further complications that can develop. Furthermore, the ongoing identification of new and specific factors contributing to the pathogenesis of APS may provide new therapeutic options in the management of the disease in the future.

Entities:  

Keywords:  Antiphospholipid antibodies; Antiphospholipid syndrome; Ocular manifestations

Year:  2021        PMID: 33834305     DOI: 10.1186/s12348-021-00240-8

Source DB:  PubMed          Journal:  J Ophthalmic Inflamm Infect        ISSN: 1869-5760


  80 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 2.  Diagnosis and Management of the Antiphospholipid Syndrome.

Authors:  David Garcia; Doruk Erkan
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

Review 3.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

Review 4.  Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  Philip G de Groot; Bas de Laat
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-16       Impact factor: 4.098

5.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

Review 6.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

Review 7.  Antiphospholipid syndrome: pathogenic mechanisms.

Authors:  Gerard Espinosa; Ricard Cervera; Josep Font; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2003-03       Impact factor: 9.754

Review 8.  Diagnosis and classification of the antiphospholipid syndrome.

Authors:  Jose A Gómez-Puerta; Ricard Cervera
Journal:  J Autoimmun       Date:  2014-01-24       Impact factor: 7.094

Review 9.  Antiphospholipid antibody syndrome.

Authors:  Paul Yang; Jonathan N Kruh; C Stephen Foster
Journal:  Curr Opin Ophthalmol       Date:  2012-11       Impact factor: 3.761

Review 10.  Primary anti-phospholipid antibody syndrome (APS): current concepts.

Authors:  Omar M Durrani; Caroline Gordon; Philip I Murray
Journal:  Surv Ophthalmol       Date:  2002 May-Jun       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.